RPG Life Sciences Ltd.

801.00 +3.90 ▲0.5%

06 June 2023, 09:07:22 AM
Volume: 15

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.rpglifesciences.com
Market Cap 1,319.40 Cr.
Enterprise Value(EV) 1,262.37 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 40.90 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 19.51 Trailing Twelve Months Ending 2023-03
Industry PE 33.51 Trailing Twelve Months Ending 2023-03
Book Value / Share 185.99 Trailing Twelve Months Ending 2023-03
Price to Book Value 4.29 Calculated using Price: 797.75
Dividend Yield 1.50 Period Ending 2022-03
No. of Shares Subscribed 1.65 Cr. 16,539,015 Shares
FaceValue 8
About RPG Life Sciences Ltd.
RPG Life Sciences (RPGLS) is a pharmaceutical organization and was formerly known as Searle (India) Limited. It is a full spectrum world class, customer focussed, innovative pharmaceutical organisation. RPGLS started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to the RPG Group. The company's name was changed to RPG Life Sciences Ltd effective April 1, 1999.This company belongs to RPG group

RPG Life Sciences Ltd. Delivery

Delivered Qty
Traded Qty

RPG Life Sciences Ltd. Performance

1 Day
+0.49%
1 Week
+5.48%
1 Month
+2.28%
3 Month
+0.75%
6 Month
-8.04%
1 Year
+55.34%
2 Year
+81.86%
5 Year
+153.84%
10 Year
+1127.59%

RPG Life Sciences Ltd. Fundamental Ratios

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 52.87 0.80 8.98 14.98 8.91 6.86 17.21 20.36 21.80
Return on Capital Employed (%) 48.37 2.50 8.97 15.58 12.52 9.81 20.35 27.27 31.46
Return on Assets (%) 25.50 0.47 5.34 9.15 5.17 4.07 11.25 14.00 15.89

RPG Life Sciences Ltd. Balance Sheet

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 126 125 134 147 155 161 177 216 256 308
Non Curr. Liab. 7 20 22 11 8 10 9 7 9 9
Curr. Liab. 77 67 67 79 121 78 83 80 80 103
Minority Int.
Equity & Liab. 209 212 223 236 284 248 268 303 345 419
Non Curr. Assets 112 126 136 140 141 151 142 127 138 155
Curr. Assets 97 86 87 96 143 97 126 176 207 264
Misc. Exp. not W/O
Total Assets 209 212 223 236 284 248 268 303 345 419

RPG Life Sciences Ltd. Profit and Loss

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 236 242 279 294 344 330 376 389 440 513
Other Income 3 7 2 10 2 1 1 1 3 5
Total Income 238 249 281 303 346 331 377 390 443 518
Total Expenditure -224 -234 -257 -265 -307 -296 -316 -318 -353 -410
PBIDT 14 15 24 38 39 35 61 72 90 107
Interest -3 -3 -2 -4 -5 -5 -3 -2 -1 0
Depreciation -11 -11 -10 -11 -14 -15 -16 -16 -16 -16
Taxation -12 -2 -7 -4 -7 -14 -22 -24
Exceptional Items 64 -5
PAT 53 1 12 21 13 11 29 40 51 68
Adjusted EPS 32 1 7 13 8 7 18 24 31 41

RPG Life Sciences Ltd. Cash Flow

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 12 -6 -2 33 7 15 46 50 58 65
Cash Fr. Inv. -12 59 -10 -15 -30 -16 -19 -11 -8 -35
Cash Fr. Finan. 0 -54 12 -18 23 0 -27 -39 -10 -14
Net Change 0 0 0 1 -1 0 0 40 17
Cash & Cash Eqvt 0 0 0 0 1 0 0 1 40 57

RPG Life Sciences Ltd. Shareholding Pattern

9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 72.07 72.07 72.07 72.07 72.07 72.41 72.61 72.61 72.81
Public 27.93 27.93 27.93 27.93 27.93 27.59 27.39 27.39 27.19
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

RPG Life Sciences Ltd. Announcements

Tue, 30 May 2023
Loss of Share Certificates
Please find enclosed herewith intimation of the loss of share certificate as received by us from LinkIntime India Private Limited, our Registrar and Share Transfer Agent, being submitted to you pursuantto Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Kindly take the same on record
Fri, 26 May 2023
Annual Secretarial Compliance Report
Please find enclosed the Annual Secretarial Compliance Report pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, issued by the Practicing Company Secretary.Kindly take the same on record.
Thu, 25 May 2023
Annual Secretarial Compliance Report
Please find enclosed the Annual Secretarial Compliance Report pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, issued by the Practicing Company Secretary.Kindly take the same on record.

RPG Life Sciences Ltd. Technical Scans

Mon, 05 Jun 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week High Close Crossing Last Week High
Closing Above Previous High Closing Above Previous High

RPG Life Sciences Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 242,260.85 1,008.90 +0.0%
Divi's Laboratories Ltd. 91,882.66 3,462.95 +0.0%
Cipla Ltd. 78,680.17 972.90 -0.2%
Dr. Reddy's Laboratories Ltd. 76,651.29 4,610.00 +0.1%
Apollo Hospitals Enterprise Ltd. 71,154.71 4,969.00 +0.4%
Torrent Pharmaceuticals Ltd. 60,075.76 1,772.25 -0.2%
Mankind Pharma Ltd. 57,049.80 1,430.80 +0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.59 1,008.90 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 50.39 3,462.95 +0.0%
Cipla Ltd. Consolidated 2023-03 28.08 972.90 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.04 4,610.00 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.87 4,969.00 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.12 1,772.25 -0.2%
Mankind Pharma Ltd. Standalone 2022-03 42.73 1,430.80 +0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.33 1,008.90 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7.20 3,462.95 +0.0%
Cipla Ltd. Consolidated 2023-03 3.36 972.90 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.30 4,610.00 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.50 4,969.00 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.66 1,772.25 -0.2%
Mankind Pharma Ltd. Standalone 2022-03 5.49 1,430.80 +0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,008.90 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,462.95 +0.0%
Cipla Ltd. Consolidated 2022-03 0.04 972.90 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,610.00 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,969.00 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,772.25 -0.2%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,430.80 +0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.90 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,462.95 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 972.90 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.00 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,969.00 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,772.25 -0.2%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,430.80 +0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.90 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,462.95 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 972.90 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.00 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,969.00 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,772.25 -0.2%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,430.80 +0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,008.90 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,462.95 +0.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 972.90 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,610.00 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,969.00 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,772.25 -0.2%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,430.80 +0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,008.90 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,462.95 +0.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 972.90 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,610.00 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,969.00 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,772.25 -0.2%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,430.80 +0.5%

RPG Life Sciences Ltd. FAQ's

What is RPG Life Sciences share price?

Can I buy RPG Life Sciences shares now?

What is the Dividend Yield of RPG Life Sciences?

What is the Market Cap of RPG Life Sciences?

What are the key metrics to analyse RPG Life Sciences?

What is the 52 Week High and Low of RPG Life Sciences?

What is the trend of RPG Life Sciences share price?